Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
NBSE similar filings
- 13 Aug 14 Ohr Pharmaceutical Announces Additional Squalamine Eye Drop (OHR-102) Phase II Clinical Data in Wet-AMD; The IMPACT Study
- 13 Aug 14 Report of Independent Registered Public Accounting Firm
- 11 Aug 14 Ohr Pharmaceutical Announces Squalamine Eye Drop (OHR-102) Phase II Clinical Data in Retinal Vein Occlusion
- 24 Jun 14 Regulation FD Disclosure
- 2 Jun 14 Strengthens Executive Management Team
- 16 May 14 Ohr Pharmaceutical Announces Agreement to Acquire Technology Assets of SKS Ocular
- 9 May 14 Ohr Pharmaceutical Announces Initiation of Investigator Sponsored Trial of Squalamine Eye Drops in Diabetic Macular Edema
Filing view
External links